Knowledge Hub | Nice Insight

Subscribe

Knowledge Hub
Pharma’s Almanac

Mobile Navigation

Subscribe for the Newsletter

Loading…

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Subscribe for the newsletter

Advanced Therapies
Traditional Biologics
Sterile Fill/Finish
Oral Solid Dose
Small Molecule – API

Topics & Trends

Capacity
Market
Manufacturing
Development
Analytical
Regulatory
Investment
Talent
Technology

Mammalian Cell Culture, Biologics
Microbial Fermentation, Biologics
Antibody-Drug Conjugate, ADC
Sterile Fill Finish
Gene Therapy
Messenger Ribonucleic Acid, mRNA
Plasmids
Active Pharmaceutical Ingredients, API
Oral Solid Dose, OSD

State of the industry

2026 State of the Industry
2025 State of the Industry

© 2026 PHARMA’S ALMANAC. All rights reserved.

Privacy Policy Terms And Conditions

Loading…

Knowledge Hub

Sort By

Mobile Filter Sidebar

1 / 1

The Gut–Brain Axis and the Future of Microbiome-Directed Mental Health Strategies

Gut-Brain Axis

The Gut–Brain Axis and the Future of Microbiome-Directed Mental Health Strategies

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-22May 25, 2026

The CMC Challenge for Psychedelic Drugs

Psychedelics CMC

The CMC Challenge for Psychedelic Drugs

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-21May 22, 2026

Rebuilding the Psychiatric Drug Discovery Pipeline

Psych R&D

Rebuilding the Psychiatric Drug Discovery Pipeline

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-14May 13, 2026

Beyond Symptoms: The Search for Objective Biomarkers in Psychiatric Disorders

Psych Biomarkers

Beyond Symptoms: The Search for Objective Biomarkers in Psychiatric Disorders

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-13May 12, 2026

1 / 1